Taehoon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taehoon Kim has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Allen M. Samarel
From the Cardiovascular Institute, Loyola University Chicago, Stritch School of Medicine, Maywood, Ill
1 shared publication - Miensheng Chu
Department of Cellular and Molecular Medicine and Sarver Molecular Cardiovascular Research Program (M.C., S.M.N., C.C., A.A.W., C.C.G.).
1 shared publication Rekha Iyengar
From the Cardiovascular Institute (Y.E.K., T.K., M.C., S.J.E., R.I., and A.M.S.), Loyola University Medical Center, Maywood, Ill; the Department of Medicine (Y.E.K., T.K., R.I., and A.M.S.), Loyola University Medical Center, Maywood, Ill; and the Department of Physiology (M.C. and S.L.R.), Loyola University Medical Center, Maywood, Ill
1 shared publication- Seth L. Robia
Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, Illinois, USA
1 shared publication Steven J. Engman
From the Cardiovascular Institute (Y.E.K., T.K., M.C., S.J.E., R.I., and A.M.S.), Loyola University Medical Center, Maywood, Ill; the Department of Medicine (Y.E.K., T.K., R.I., and A.M.S.), Loyola University Medical Center, Maywood, Ill; and the Department of Physiology (M.C. and S.L.R.), Loyola University Medical Center, Maywood, Ill
1 shared publicationYevgeniya E. Koshman
Cardiovascular Institute, Loyola University Medical Center, 2160 S First Ave, Maywood, IL 60153, USA
1 shared publication
Latest Publications
- Open Access
- 1 November 2010
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (11) , 2226-2233
FRNK Inhibition of Focal Adhesion Kinase–Dependent Signaling and Migration in Vascular Smooth Muscle Cells
Objective— To examine whether interference with FRNK targeting to focal adhesions (FAs) affects its inhibitory activity and tyrosine phosphorylation. Methods and Results— Focal adhesion kinase and its autonomously expressed C-terminal inhibitor, focal adhesion kinase–related nonkinase (FRNK), regulate vascular smooth muscle cell (VSMC) signaling and migration. FRNK-paxillin binding was reduced by a point mutation in its FA targeting domain (L341S-FRNK). Green fluorescent protein–tagged wild type and L341S-FRNK were then adenovirally expressed in VSMCs. L341S-FRNK targeted to VSMC FAs, despite previous studies in other cell types. L341S-FRNK affected FA binding kinetics (assessed by total internal reflection fluorescnece [TIRF] microscopy and fluorescence recovery after photobleaching [FRAP]) and reduced its steady-state paxillin interaction (determined by coimmunoprecipitation). Both wt-FRNK and L341S-FRNK lowered basal and angiotensin II–stimulated focal adhesion kinase, paxillin, and extracellular signal–regulated kinase 1/2 phosphorylation. However, the degree of inhibition was significantly reduced by L341S-FRNK. L341S-FRNK also demonstrated significantly greater migratory activity compared with wt-FRNK–expressing VSMCs. Angiotensin II–induced Y168 phosphorylation was Src dependent, as evident by a significant reduction in Y168 phosphorylation by the Src family kinase inhibitor PP2 is 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). Surprisingly, Y168 phosphorylation was unaffected by its targeting. Furthermore, Y232 phosphorylation increased approximately 3-fold in L341S-FRNK, which was less sensitive to PP2. Conclusion— FRNK inhibition of VSMC migration requires both FA targeting and Y168 phosphorylation by Src family kinases. FRNK-Y232 phosphorylation occurs outside of FAs, probably by a PP2-insensitive kinase.
- 1 November 2010
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (11) , 2226-2233
Open AccessFRNK Inhibition of Focal Adhesion Kinase–Dependent Signaling and Migration in Vascular Smooth Muscle Cells
Objective— To examine whether interference with FRNK targeting to focal adhesions (FAs) affects its inhibitory activity and tyrosine phosphorylation. Methods and Results— Focal adhesion kinase and its autonomously expressed C-terminal inhibitor, focal adhesion kinase–related nonkinase (FRNK), regulate vascular smooth muscle cell (VSMC) signaling and migration. FRNK-paxillin binding was reduced by a point mutation in its FA targeting domain (L341S-FRNK). Green fluorescent protein–tagged wild type and L341S-FRNK were then adenovirally expressed in VSMCs. L341S-FRNK targeted to VSMC FAs, despite previous studies in other cell types. L341S-FRNK affected FA binding kinetics (assessed by total internal reflection fluorescnece [TIRF] microscopy and fluorescence recovery after photobleaching [FRAP]) and reduced its steady-state paxillin interaction (determined by coimmunoprecipitation). Both wt-FRNK and L341S-FRNK lowered basal and angiotensin II–stimulated focal adhesion kinase, paxillin, and extracellular signal–regulated kinase 1/2 phosphorylation. However, the degree of inhibition was significantly reduced by L341S-FRNK. L341S-FRNK also demonstrated significantly greater migratory activity compared with wt-FRNK–expressing VSMCs. Angiotensin II–induced Y168 phosphorylation was Src dependent, as evident by a significant reduction in Y168 phosphorylation by the Src family kinase inhibitor PP2 is 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). Surprisingly, Y168 phosphorylation was unaffected by its targeting. Furthermore, Y232 phosphorylation increased approximately 3-fold in L341S-FRNK, which was less sensitive to PP2. Conclusion— FRNK inhibition of VSMC migration requires both FA targeting and Y168 phosphorylation by Src family kinases. FRNK-Y232 phosphorylation occurs outside of FAs, probably by a PP2-insensitive kinase.